Deep learning has been applied to various medical data. In particular, current deep learning models exhibit remarkable performance at specific tasks, sometimes offering higher accuracy than that of experts for discriminating specific diseases from medical images. The current status of deep learning applications to molecular imaging can be divided into a few subtypes in terms of their purposes: differential diagnostic classification, enhancement of image acquisition, and imagebased quantification. As functional and pathophysiologic information is key to molecular imaging, this review will emphasize the need for accurate biomarker acquisition by deep learning in molecular imaging. Furthermore, this review addresses practical issues that include clinical validation, data distribution, labeling issues, and harmonization to achieve clinically feasible deep learning models. Eventually, deep learning will enhance the role of theranostics, which aims at precision targeting of pathophysiology by maximizing molecular imaging functional information.
Introduction
Deep learning rapidly begins to be applied in the medical field. Recently, several deep learning-related medical devices and softwares have been developed and started to be applied in the clinical fields. 1) The major contribution of deep learning to medical data was to objectively evaluate high-dimensional medical data and remarkably reduce laborious works such as segmentation and object detection from high-resolution images. The major medical application is medical imaging fields as a boom of deep learning was started from the computer vision field initiated by ImageNet Challenge. 2, 3) The methods and neural network architectures developed for ImageNet Challenge have been applied to medial images including radiologic and pathologic exams as well as natural photographic images. These approaches based on computer vision fields have showed remarkable performance in differential diagnosis. For natural photographic images such as skin images and fundoscopy deep learning techniques were relatively easily adopted as convolutional neural network (CNN) models developed for ImageNet Challenge were directly transferred to such images. 4, 5) Moreover, CNN which show good performance on image classification and processing have been applied to radiologic exams such as chest X-ray and mammography. [6] [7] [8] Subsequently, CNN models have been used for image-based diagnosis as well as image processing. 9 In order to develop robust deep learning models and guide their appropriate direction for clinical use, practical issues of current deep learning are introduced in this review. PET and MRI images for diagnosing AD. 17, 18) Though these pioneer studies did not use CNN, regarded as a de facto standard model in recent application, these models extract discriminative features automatically and showed higher performance for classifying brain images of AD compared with conventional algorithms. Recently developed models use deep CNN models for differentiating AD from controls, and showed high accuracy for the differentiation. 13, 45) Another important application is enhancement of image reconstruction and image quality. For example, CNN models were incorporated into iterative reconstruction framework and showed better performance than conventional denoising algorithms. 27) As a generalized approach, deep learning was used to solve the inverse function of signals encoded by sensors including MRI and PET with regard to 46, 47) Recently suggested deep learning-based CT image synthesis using MR or PET images is promising to solve the quantification issues caused by attenuation correction. [30] [31] [32] [33] [34] Additionally, deep learning has been used to enhance image quality for low dose PET images. [35] [36] [37] By combining the algorithms for image reconstruction with low-dose radiotracers and PET-or MR-based attenuation correction can dramatically reduce radiation exposure in the future. Such an ultra-low dose PET may be used for new clinical purposes including disease screening which has been difficult to obtain benefits due to radiation hazards.
Current Deep Learning Models for Molecular Imaging
As molecular imaging provides quantitative value related to pathophysiology, studies have focused on the application of deep learning to obtain accurate quantification.
The most common application of deep learning to medical images is segmentation. 9) The segmentation methods are usually based on anatomical images such as CT and MRI.
As recent clinical molecular imaging modalities provides fusion images such as PET/CT, PET/MR, and SPECT/CT, deep learning-based segmentation methods can be used to calculate quantitative values such as the accumulation of radiotracer in a specific tissue delineated by anatomical imaging. 39, 48) The quantification can be improved by generative models such as generative adversarial networks (GAN). For example, pseudo-MR images were generated by AV-45 PET using GAN for the quantification of cortical radiotracer uptake without structural MR acquisition. 43) 
Clinically Feasible Deep Learning-Based Biomarkers and Practical Issues

Necessity of deep learning-based biomarker
Even though various deep learning techniques have ap-plied to molecular imaging for differential diagnosis, image enhancement, and accurate quantification, there are many issues that need to be solved in order to be clinically used.
One of the gaps between deep learning approaches for natural image recognition and medical images, particularly molecular imaging, is placed on the purpose of imaging.
While the image recognition task has simple labels, clinicians often require various types of information from medical images. They include prediction of prognostic outcome and treatment response as well as differential diagnosis. 10) In a narrower range, differential diagnosis is similar with labels of natural images; however, many diagnostic clas- and amyloid deposit in the brain, these patterns could be associated with a predictive biomarker for the outcome of MCI subjects (Fig. 1) . 2 ). This is the reason why deep learning models should be subjected to clinical trials in spite of the high accuracy, and it is necessary to make appropriate use criteria and use it clinically under limited clinical situations.
Uncertainty and unseen data
The issues regarding data distribution and 'unseen data' Bayesian approximation with DL for uncertainty measurement is a good example for supervised learning models. 54) Another way to bypass the issue regarding uncertainty and unseen data, particularly rare disorders, is to employ unsupervised learning for the anomaly detection. As deep learning is representation learning, latent features in imaging data could show distribution according to training datasets. After the definition of distribution of latent features in the training data, unseen data can be identified by the definition in the latent space. 55, 56) As conditional generative models such as conditional generative adversarial networks (GAN) or variational autoencoders (VAE) synthesize virtual data of specific conditions, it can be used to define a population distribution of specific conditions. For example,
by training a generative model for normal aging changes in brain metabolism, a pseudo-population distribution of brain metabolism at each age can be generated. 57) This generated population distribution will be used to find abnormal patterns taking age information into consideration from a given brain image. This type of anomaly detection can bypass the issue related to deep learning models for heterogeneous disorders. be a data-driven approach to develop biomarker without a priori knowledge. The self-supervised learning will be one of the future directions of a data-driven approach and will be achieved by using a text report or intrinsic information, such as age and gender matched with image data.
Labeling of data: leveraging unlabeled data
Data harmonization
One of the overlooked practical issues is data harmoni- 
